Scientists Report Early Progress in Tissue
Engineering Mandibular Condyle
Tissue engineering holds
much promise for the future. Although
JJAMD fights for current awareness and prevention programs, we also support
future progress towards eventual cure. The
following release from NIDCR addresses such progress, but the patients must
remember that such research will take years before there is an actual
application to the patients.
Researchers have long
dreamed of engineering new knees, hips and other body joints in the laboratory
from a person’s own bone and cartilage producing adult stem cells. The
challenge has been to figure out how to manipulate these cells and get them to
form tissues that precisely mirror the natural three-dimensional structure and mechanical
strength of our normal, healthy joints.
Now, in an important first step
toward realizing this dream, scientists report in this month’s issue of the
Journal of Dental Research that they have created a mandibular
condyle from rat adult stem cells that is the precise
three-dimensional shape of the human joint. A mandibular
condyle is the knobbed ending of the lower jaw; it
joins the lower jaw to the temporal bone of the skull on both sides of the head
at the temporomandibular joint, or TMJ.
Stressing that their findings are
preliminary and significant scientific challenges lie ahead, the researchers
said the results are hopeful because they produced their structure from a
single population of stem cells and prompted them to form two distinct layers
of bone and cartilage, a characteristic feature of a condyle
and a first in the field of tissue engineering. According to Jeremy Mao, D.D.S,
Ph.D., a scientist at the
“The TMJ is a synovial,
or free-moving, joint,” said Mao, whose work is supported by NIH’s National Institute of Dental and Craniofacial
Research (NIDCR). “So are the knee, hip, and shoulder joints, all of which
include rounded, moveable condyles. We certainly hope
our results will be applicable to other synovial
joints.”
Coined in 1987, the term “tissue
engineering” combines principles from engineering and the life sciences in a
bold attempt to use the body’s own biological materials to repair, regenerate,
and ultimately replace damaged organs and tissues, including bone and
cartilage. If successful, tissue engineering would eliminate the need for bone
grafts and avoid problems associated with artificial replacement joints, such
as donor site defects, immunorejection, abnormal wear
and tear, and transmission of pathogens.
As tissue engineers have studied
the hips, knees, and other joints, most of their work to date has focused on
the initial step of repairing a small area of damaged tissue. According to Mao,
while studies in this area have tremendous therapeutic potential, he and his
colleagues realized that these strategies might be somewhat limited in people
with severe arthritis. “People with very severe osteoarthritis or rheumatoid
arthritis often have large condyle defects, so the
entire condyle needs to be replaced,” said Mao.
About two years ago, Mao and his
team of clinicians, dentists, surgeons, cell biologists, and materials
scientists decided to take the next step and engineer a mandibular
condyle. “Why the mandibular condyle?” answered
Adel Alhadlaq, D.D.S., M.S., a coauthor on the paper
and also a scientist at the
At the same time, Mao said his
research team has had a long-standing research interest in temporomandibular
joint disorders. These sometimes painful conditions affect an estimated 90
million Americans, and, for those with severe damage to the joint itself, a
tissue-engineered mandibular condyle
one day could have tremendous clinical benefits.
As reported this month in the
Journal of Dental Research, Mao’s group succeeded in their efforts. The group
isolated adult mesenchymal stem cells from rat bone
marrow, then treated them in the laboratory to
differentiate into either bone or cartilage producing cells called osteoblasts and chondrocytes.
Each adult mesenchymal stem cell can produce
thousands of individual osteoblasts or chondrocytes.
Thereafter, the group seeded the
differentiated cells into a hydrogel polymer
solution, and placed their creation into a polyurethane mold made from a human mandibular condyle. The
scientists then implanted three small molded structures just below the skin of
severe combined immunodeficient (SCID) mice. Each
implant now was encapsulated in a hydrogel coat that
was subdivided into layers seeded either with osteoblasts
or chondrocytes, an attempt to engineer distinct
layers of bone and cartilage.
Eight weeks later, Mao and
colleagues harvested the three tissue-engineered condyles
from the mice. They found the implants had formed on their own into “firm”
structures that retained the precise shape and three-dimensional structure of
the molded human mandibular condyle.
Importantly, within the layer of
the implants seeded with osteoblasts, the scientists
detected mineral deposits in island structures, a sign that the osteoblasts had followed their biological program and
produced bone. In the other layer, they identified “sparse chondrocyte-like
cells within abundant extracelluar matrix” that
expressed certain proteins characteristic of cartilage.
In future work, Mao said he and his
team will attempt to enhance the biological and mechanical properties of the
tissue-engineered condyles. However, Mao stresses
that these results are just the start of a much steeper scientific challenge.
“It is no small task by any measure to recapitulate what nature does perfectly
during development,” he said. “Although we understand many of these cues during
natural development, we need to learn how to utilize them to tissue engineer mandibular condyles.”
“But we have designed several
approaches to solving the problems, and enhancing the tissue-forming capacity
of engineered mandibular condyles.
This will be the central focus of our NIDCR grant over the next few years,”
added Mao.
The NIDCR, part of the National
Institutes of Health, is the federal government’s lead agency in the conduct
and support of dental research. For more information about NIDCR, please visit
www.nidcr.nih.gov or call (301) 496-4261.